Floatz logo

Ranolazine

Coronary Artery Disorder

OBS PakistanSmall moleculePhase 4 / ApprovedDormant
BBB
75/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
66/ 100
Competitive Position
89/ 100

Competitive context

16 Active assets in the Coronary Artery Disorder cohort.

Asset / SponsorPhaseRating
Aspirin
Rajaie Cardiovascular Medical and Research Center
Phase 4BBB
Ezetimibe
Canadian Collaborative Research Network
Phase 4BBB
SIMVASTATIN
University of Washington
Phase 4BBB
Rivaroxaban
Sheffield Teaching Hospitals NHS Foundation Trust
Phase 4BBB
Itavastatin
Yokohama City University Medical Center
Phase 4BBB

View all 48 →

Same molecule, other indications

Ranolazine is also rated in:

myocardial ischemiaDormant
A
Indicative · Phase 4
82 / 100
View asset →
type 2 diabetes mellitusDormant
BB
Indicative · Phase 4
68 / 100
View asset →
arteriosclerosis disorderDormant
BB
Indicative · Phase 4
65 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →